Vasculitis, Raynaud's phenomenon and polyarthritis associated with gemfibrozil therapy.
Smith
G W
GW
Hurst
N P
NP
D000328:Adult; D001168:Arthritis / Q000139:chemically induced* / Q000150:complications*; D015248:Gemfibrozil / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D008297:Male; D011928:Raynaud Disease / Q000139:chemically induced* / Q000150:complications*; D014657:Vasculitis / Q000139:chemically induced* / Q000150:complications*
D015248:Gemfibrozil